Loading...
A Cell surface β-Hydroxylase is a biomarker and therapeutic target for hepatocellular carcinoma
Hepatocellular carcinoma (HCC) has a poor prognosis due to widespread intrahepatic and extrahepatic metastases. There is an urgent need to understand signaling cascades that promote disease progression. Aspartyl-(Asparaginyl)-β-hydroxylase (ASPH) is a cell surface enzyme that generates enhanced cell...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2014
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4176525/ https://ncbi.nlm.nih.gov/pubmed/24954865 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.27275 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|